Skip to main content

Does Finasteride Cause Low Libido and Depression in Women

What sexual side effects have been reported in women taking finasteride?

Think of the evidence as a set of layers, with the clearest findings on top and the murkier reports underneath. Decreased libido is the complaint you'll see most consistently, and most female hair loss studies at 1 to 5 milligrams a day found sexual effects in only a small minority. Those studies rarely asked about sex in a structured way, though, so quieter or embarrassing symptoms may never have made it into the record.

Most consistent: A noticeable drop in interest in sex after starting treatment.
Seen across female hair loss studies, usually in a small minority of participants
Less common: Reduced arousal, vaginal dryness or difficulty reaching orgasm.
Drawn mostly from individual case reports and small patient series
Indirect: Breast tenderness, breast enlargement or menstrual changes that affect comfort and body image.
Can wear on sexual well-being even without a direct effect on desire
Expert Insight

Decreased libido is the most consistently reported sexual side effect in women taking finasteride, typically at doses of 1 to 5 milligrams daily.

What mood and psychiatric symptoms have been linked to finasteride use in women?

I don't want you brushing off a mood change as just a rough patch when regulators on both sides of the Atlantic have flagged this drug for depression and suicidal thoughts. Most of those reports come from men, but the label doesn't say women are exempt, and the female case reports describe low mood, tearfulness, anxiety and irritability.

If you notice mild shifts like irritability, poor sleep or trouble focusing: Note when they started and raise them with your prescriber soon.
If sadness persists or you've lost interest in things you usually enjoy: Call your prescriber promptly, since this is the pattern the warnings describe.
If you feel hopeless or have any thoughts of self-harm: Seek urgent help right away through emergency services or a crisis line.
Where It Goes Wrong

United States prescribing information for finasteride lists depression and suicidal ideation among effects reported after the drug reached the market.

How could blocking 5-alpha reductase affect sexual function and mood in women?

Most people think finasteride does one job, cutting the hormone that shrinks hair follicles, but the enzyme it blocks also helps your brain make a calming neurosteroid. That second job is why a hair loss pill could plausibly touch your mood and your desire at the same time.

  • DHT pathway: Blocks conversion of testosterone to dihydrotestosterone, which supports desire and genital sensitivity.
  • Neurosteroid pathway: Reduces allopregnanolone, a GABA-A-acting neurosteroid tied to steady mood.
  • Why women count: Reproductive-age women make meaningful progesterone, the raw material for allopregnanolone.
  • Open question: Finasteride mainly hits type 2 enzyme, while type 1 dominates some brain regions.
Critical Insight

The 5-alpha reductase enzyme that finasteride blocks converts testosterone into dihydrotestosterone and also helps produce allopregnanolone, a mood-stabilizing neurosteroid that acts on GABA-A receptors.

How reliable is the evidence on these side effects in women compared with men?

The evidence in women is weak, and it's weaker than the evidence in men, which is already argued over. Here's how the two stack up side by side.

Criteria Women Men
Study design Small open-label trials, chart reviews Large placebo-controlled trials
Typical size Dozens to a few hundred Large trial populations
Side effect rates Uncertain Firm, though contested
Approval status Off-label only Approved use
Worth Understanding

Finasteride's firm side effect rates come from large placebo-controlled trials in men, while studies in women typically enrolled only dozens to a few hundred participants and can't reliably detect uncommon events like depression.

Which women may be more vulnerable to sexual or mood side effects on finasteride?

No risk factors have actually been proven here, so the watch list is built on caution rather than hard data. That said, your starting point matters, and a few situations make a new symptom either more serious or harder to pin on the right cause.

  • Psychiatric history: Past or current depression or anxiety gets the closest watch from prescribers.
  • Other medicines: Antidepressants, hormonal contraception, hormone therapy or anti-androgens muddy who's responsible.
  • Life stage: Premenopausal women make more progesterone; postmenopausal women may already have lower desire.
  • Pregnancy potential: Reliable contraception is required because of the risk to a male fetus.
Safety Note

Women with a past or current history of depression or anxiety are the group clinicians watch most closely on finasteride, even though no risk factor has been proven.

What should a woman do if she notices sexual or mood changes while taking finasteride?

Treat this like any good repair job: secure the scene first, then gather your notes, then decide on the fix with your prescriber. Stopping the pill on your own isn't the whole answer, because your hair loss still needs a plan.

  1. Check for urgency: Thoughts of suicide or self-harm, or a sudden severe mood drop, mean emergency services or a crisis line now.
  2. Call your prescriber: For lowered desire, irritability or a flat mood, get in touch promptly instead of waiting it out.
  3. Bring a record: Start date, dose, when symptoms began, whether they're changing, plus other medicines and life events.
  4. Decide together: Many clinicians advise stopping when mood symptoms appear, then weigh minoxidil, spironolactone or procedural options.
  5. Treat and report: Get mental health or sexual health support, and file a report with a national side effect reporting system.
Pro Tip

Any thoughts of suicide or self-harm while taking finasteride call for immediate help through emergency services or a crisis line, not a wait for the next scheduled visit.

Do sexual and mood side effects go away after finasteride is stopped?

For most people, things settle down once the pill is gone, since the hormone levels it shifts drift back toward baseline within weeks. The harder part is the small group whose symptoms hang on, and you've got to know there's almost no data on whether that happens to women.

Typical course: Symptoms ease after stopping as affected hormone levels return toward baseline within weeks.
Any hair regrowth from treatment also fades gradually over the following months
Persistent symptoms: Post-finasteride syndrome describes lasting sexual, mental and physical complaints after stopping.
Reports come overwhelmingly from men, with no agreed diagnostic criteria or test
No improvement after a few months: Don't assume it's permanent, and don't dismiss it either.
A medical review should check thyroid function, menopause, other medications and primary mood disorders
Longevity Note

For most people who report sexual or mood effects on finasteride, symptoms ease after stopping, with affected hormone levels generally returning toward baseline within weeks.

How does the side effect profile of finasteride compare with other hair loss treatments used by women?

Choosing a hair loss treatment is really choosing which kind of risk you're willing to carry. Finasteride is the one with mood warnings on its label, but spironolactone brings its own hormonal baggage, and minoxidil trades those worries for effects on your blood vessels.

Criteria Finasteride Spironolactone Minoxidil
How it works Blocks 5-alpha reductase Anti-androgen Acts on blood vessels
Mood warning Depression, suicidal ideation None specific No established link
Sexual effects Reduced libido reported Reduced libido in some No established link
Main other concerns Breast tenderness, pregnancy risk Irregular periods, high potassium Unwanted hair, fluid retention
The Trade-Off

Finasteride carries depression and suicidal ideation warnings that spironolactone doesn't, while minoxidil acts on blood vessels rather than hormones and has no established link to sexual dysfunction or depression.

Daniel Zengel
Written by Daniel Zengel
Medical Writer
Daniel Zengel is the principal owner of H-SHOT and a medical writer covering platelet-rich plasma and hair restoration. He draws on more than a decade in pharmaceutical and medical device roles, with a focus on regenerative medicine and the device standards and provider training that make PRP results consistent from clinic to clinic.